U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 5, 2010
Cannabis Medical Solutions, Inc.
(Name of small business issuer as specified in its charter)
Delaware |
(State or other jurisdiction of incorporation) |
000-1321002 |
| 20-8484256 |
(Commission File Number) |
| (I.R.S. Employer |
|
| Identification No.) |
18565 Soledad Canyon Road #153
Canyon Country, Ca. 91351
(310) 309-9080
(Issuer’s telephone number)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2 below):
. Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
. Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
. Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
. Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
As used in this report, the terms "we", “us", “our", “our company" refer to Cannabis Medical Solutions, Inc., a Delaware corporation.
CHANGES IN REGISTRANT AND MATERIAL EVENTS
Section 8.01 OTHER EVENTS: Name Change, Reverse Split & Symbol Change
Effective March 4, 2010, the name of the Company was changed to “Cannabis Medical Solutions, Inc.”
Additionally, also effective March 4, 2010, the Company’s trading symbol was changed to “CMSI” in conjunction with the name change of the Company.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Cannabis Medical Solutions, Inc.
By: /s/ Kyle Gotshalk
Kyle Gotshalk, CEO
Date: March 5, 2010
3